FDMT icon

4D Molecular Therapeutics
FDMT

Overview Fund Activity

139 hedge funds and large institutions have $625M invested in 4D Molecular Therapeutics in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
-4
Holders Change %
-2.8%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
57
Reduced
44
Closed
25
Calls
$1.66M
Puts
$1.21M
Net Calls
+$455K
Net Calls Change
+$3.8M

Top Buyers

1
BI
1
BVF Inc
California
$79.8M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$16.7M
3
B
3
Braidwell
Connecticut
$13.2M
4
Deutsche Bank
4
Deutsche Bank
Germany
$8.68M
5
CC
5
Casdin Capital
New York
$12.4M

Top Sellers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$44.3K
3
PCH
3
Polar Capital Holdings
United Kingdom
$9.06M
4
OM
4
Opaleye Management
Massachusetts
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$38.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
BHCM
151
Brevan Howard Capital Management
Jersey
– -$233K -11,079 Closed
BC
152
Bridgefront Capital
Texas
– -$213K -10,171 Closed
EWM
153
Elmwood Wealth Management
California
– -$206K -9,800 Closed
Capstone Investment Advisors
154
Capstone Investment Advisors
New York
– -$200K -9,548 Closed
Group One Trading
155
Group One Trading
Illinois
– -$43.3K -2,065 Closed
Pacer Advisors
156
Pacer Advisors
Pennsylvania
– -$11.4K -544 Closed
BL
157
BFSG LLC
California
– -$10.5K -500 Closed
SAM
158
Smartleaf Asset Management
Massachusetts
– -$1.7K -81 Closed
AF
159
Allworth Financial
California
– -$404 -28 Closed
IC
160
Innealta Capital
Texas
– -$84 -4 Closed
3 4 5 6
7